社区

$Novavax(NVAX)$ Companies with large user base succeed. Companies with great customer experience are successful. And, that same principle apply to covid vaccines as well. In long run, those vaccines with the largest user base giving the best vaccine result will be champion of all vaccine. In 2022, Novavax will provide the world with 1.5 B dose of Novavax vaccine thru Serum Institutue for low income nations. And, for economicall well off nations, Novavax will sell 1.5 B doses at normal price. That means 3 B doses in 2022. Simply put, Novavax will have the largest Novavax covid vaccine user population base. And, Novavax is safe enough to use on AIDs patient based on Novavax's Africa clinical trial. Such safety feature strength result in high user satifaction from the Novavax vaccine. It is true, Novavax lost golden opportunity to sell crazy like moderna or pfier vaccine with those delayin FDA filing process. Novavax was busy increasing manufacturing capacity. in 2022, such large manufacturing capacity will finally pay off.$Pfizer(PFE)$